Why Did MLYS Soar 15.76%? Wellington Management Boosts Stake

Mineralys Therapeutics, Inc. (MLYS) surged 15.76% in pre-market trading on September 2, 2025, reflecting a significant bullish sentiment among investors.

Wellington Management Group LLP has increased its stake in Mineralys Therapeutics, Inc. (MLYS), indicating a strong confidence in the company's future prospects. This move by a prominent investment firm suggests that Mineralys may be poised for further growth, potentially driven by strategic investments and market opportunities.

The increased institutional interest in Mineralys Therapeutics, Inc. (MLYS) underscores the company's potential for growth and innovation. As more investors recognize the value in Mineralys, the stock is likely to continue attracting attention, potentially leading to further price appreciation.